These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30207230)

  • 1. The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View.
    Penke B; Paragi G; Gera J; Berkecz R; Kovács Z; Crul T; VÍgh L
    Curr Alzheimer Res; 2018; 15(13):1191-1212. PubMed ID: 30207230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of amyloid beta in lipid homeostasis.
    Grösgen S; Grimm MO; Friess P; Hartmann T
    Biochim Biophys Acta; 2010 Aug; 1801(8):966-74. PubMed ID: 20452461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol, lipids, amyloid Beta, and Alzheimer's.
    Vestergaard M; Hamada T; Morita M; Takagi M
    Curr Alzheimer Res; 2010 May; 7(3):262-70. PubMed ID: 19715550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Amyloid β-Biomembrane Interactions in the Pathogenesis of Alzheimer's Disease: Insights from Liposomes as Membrane Models.
    Andrade S; Loureiro JA; Pereira MC
    Chemphyschem; 2021 Aug; 22(15):1547-1565. PubMed ID: 34086399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease.
    Torres M; Price SL; Fiol-Deroque MA; Marcilla-Etxenike A; Ahyayauch H; Barceló-Coblijn G; Terés S; Katsouri L; Ordinas M; López DJ; Ibarguren M; Goñi FM; Busquets X; Vitorica J; Sastre M; Escribá PV
    Biochim Biophys Acta; 2014 Jun; 1838(6):1680-92. PubMed ID: 24374316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The essential role of lipids in Alzheimer's disease.
    Florent-Béchard S; Desbène C; Garcia P; Allouche A; Youssef I; Escanyé MC; Koziel V; Hanse M; Malaplate-Armand C; Stenger C; Kriem B; Yen-Potin FT; Olivier JL; Pillot T; Oster T
    Biochimie; 2009 Jun; 91(6):804-9. PubMed ID: 19303044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
    Poirier J
    Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids in Amyloid-β Processing, Aggregation, and Toxicity.
    Morgado I; Garvey M
    Adv Exp Med Biol; 2015; 855():67-94. PubMed ID: 26149926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease Risk Genes and Lipid Regulators.
    El Gaamouch F; Jing P; Xia J; Cai D
    J Alzheimers Dis; 2016 Apr; 53(1):15-29. PubMed ID: 27128373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.
    Drolle E; Hane F; Lee B; Leonenko Z
    Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.
    Fabiani C; Antollini SS
    Front Cell Neurosci; 2019; 13():309. PubMed ID: 31379503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.
    Gibson Wood W; Eckert GP; Igbavboa U; Müller WE
    Biochim Biophys Acta; 2003 Mar; 1610(2):281-90. PubMed ID: 12648781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.